Gero brings together deep physics, two decades of biotech operating experience, and some of the most cited names in longevity research.
Physicist-turned-biotech innovator and a top-cited physicist with a PhD from the University of Amsterdam and over 75 publications. He uses deep expertise in physics and data science to drive innovation at the intersection of AI and human health, leveraging over 20 years of experience.
Read on Substack →Biotech entrepreneur with 20+ years of experience, Maxim co-founded Gero to develop therapies against aging. He leads corporate affairs, legal strategy, fundraising, and investor relations, holding master's degrees in law and economics. His mission is to end age-related diseases through science-enabled progress, having initiated and closed numerous licensing and investment deals.
Experienced tech entrepreneur and operational leader with multiple exits, including to Samsung. Aleksandr brings over a decade of expertise managing multidisciplinary teams and driving ambitious projects from concept to successful outcomes. As a longevity maximalist, he is deeply committed to Gero's mission of stopping aging and chronic diseases through cutting-edge biotech and AI innovation.
Serial tech entrepreneur and investor with a proven track record of successful exits, including acquisitions by Google, Pinterest, and Farfetch. Yuri brings deep expertise in Machine Learning, Computer Vision, and AI, coupled with a proven ability to lead companies toward sustained growth and strategic exits.
Globally renowned longevity researcher, Distinguished Professor of Biochemistry & Physiology at the National University of Singapore, and Director of the Centre for Healthy Longevity at NUHS. Brian previously served as President and CEO of the Buck Institute for Research on Aging, the premier independent aging research center in the U.S. He also holds adjunct professorship at USC's Leonard Davis School of Gerontology, among other academic roles, and brings deep expertise in translating cutting-edge science into transformative therapies against aging and age-related diseases.
Founder and COO at Connected Discovery Ltd. Ex SVP of Drug Discovery at BenevolentAI.
Medicinal Chemist, ex-Eli Lilly and WuXi AppTec.
Medicinal Chemistry at Pfizer. Co-inventor of XELJANZ and CIBINQO.
Associate Professor at the National University of Singapore.
We are always interested in researchers, operators, and partners who take aging seriously as a solvable problem.
